UMC | UMEDIC GROUP BERHAD

9 9
0.345 (4.55%)

T-O (am): 0.000 (08:59:00)
Last updated: 16:34

Fundamental
Technical
Total Score
UMC | UMEDIC GROUP BERHAD

UMC Support & Resistance

ATR Trailing Stop: 0.385

Support
Last Price
Resistance
Price 0.325 0.335 0.34 0.345 0.35 0.375 0.38 0.4 0.41
Volume (M) 0.8 3.0 3.1 7.3 1.4 7.9 6.5 5.5

Gann Support: 0.34/0.31 | Resistance: 0.37/0.4

*Highlighted column shows significant volume at the support or resistance area.

UMC Technical Trend

UMC Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT
Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

UMC Pivot Point

S2
S1
P
R1
R2
Daily 0.325 0.335 0.34 0.35 0.355
Weekly 0.315 0.33 0.345 0.36 0.375

UMC Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

UMC Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
11 Sep 25 Q4 Jul 25 4 31 Jul 25 12.29 3.54 2.49 20.3% 0.00 0.67 5.6% 17.4% 30.9% 17.9%
05 Jun 25 Q3 Apr 25 3 31 Jul 25 11.64 2.41 1.90 16.4% 0.00 0.51 0.5% 0.4% 0.7% 20.3%
11 Mar 25 Q2 Jan 25 2 31 Jul 25 11.58 2.46 1.89 16.3% 0.00 0.51 11.3% 14.1% 2.5% 23.8%
04 Dec 24 Q1 Oct 24 1 31 Jul 25 13.05 2.43 1.84 14.1% 0.00 0.49 12.2% 10.1% 39.2% 2.3%
04 Sep 24 Q4 Jul 24 4 31 Jul 24 14.88 3.80 3.04 20.4% 0.00 0.81 27.2% 23.8% 91.7% 10.0%
10 Jun 24 Q3 Apr 24 3 31 Jul 24 11.69 2.27 1.58 13.5% 0.00 0.42 13.3% 22.0% 36.2% 22.2%
11 Mar 24 Q2 Jan 24 2 31 Jul 24 13.48 3.95 2.48 18.4% 0.00 0.66 7.2% 7.7% 31.3% 14.8%
04 Dec 23 Q1 Oct 23 1 31 Jul 24 14.52 2.63 1.89 13.0% 0.00 0.51 20.9% 28.4% 44.0% 5.6%
12 Sep 23 Q4 Jul 23 4 31 Jul 23 12.02 4.50 3.37 28.1% 0.00 0.90 25.4% 62.1% 65.7% 493.5%
07 Jun 23 Q3 Apr 23 3 31 Jul 23 9.59 2.46 2.04 21.2% 0.00 0.54 23.4% 48.1% 30.0% 58.2%
06 Mar 23 Q2 Jan 23 2 31 Jul 23 12.52 3.73 2.91 23.2% 0.00 0.78 10.6% 45.4%
02 Dec 22 Q1 Oct 22 1 31 Jul 23 11.31 2.25 2.00 17.7% 0.00 0.54 52.7% 252.3%
13 Sep 22 Q4 Jul 22 4 31 Jul 22 7.41 0.30 0.57 7.7% 0.00 0.15 14.5% 55.8%
22 Jul 22 Q3 Apr 22 3 31 Jul 22 6.47 1.47 1.29 19.9% 0.00 0.34

UMC Historical Dividends

UMC Financial Ratios

EPS 2.18 sen
Trailing PE (Sector Median: 22.9) 15.7
PEG 1.2
Altman Z 2.1
Beaver 1.166
Current Ratio 9.19
Debt-Equity (DE) Ratio 0.12
FCF Yield 2.68 %
Revenue QoQ 5.58 %
Revenue YoY -17.38%
Profit QoQ 30.93 %
Profit YoY -17.86 %
Profit Margin (Sector Median: 4.5) 16.75 %
ROE (ROIC: 10.15) 10.15 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

UMC Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 22.9)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 4.5)
ROE (ROIC: 10.31)
Altman Z

UMC Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 1 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.21
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 2.83
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0
Expected Revenue (M) 0
Expected Growth (%) 0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

UMC Directors Share Purchases (Beta)


No transaction in the last 2 months.

UMC Summary


Market Cap: 128 M.

Market Cap Class: Micro caps

Number of Shares: 373 M.

Adjusted Float: 37.8%.

Stock highly correlated with

SFPTECH (93%)

BAT (92%)

EPMB (91%)

NESTLE (91%)

UMediC Group Berhad is an investment holding company. Through its subsidiaries, the Group is principally involved in the marketing and distribution of various branded medical devices and consumables. It is also engaged in developing, manufacturing, and marketing its medical consumables. The Group is an authorised distributor of multiple established international medical device companies including Philips, Mindray, GE, and Merit. The Group distributes its products to its customers comprising public and private hospitals, other healthcare service providers as well as non-medical business entities. The company was incorporated in 2002 and is headquartered in Pulau Pinang, Malaysia.

Sectors: Healthcare, Health Care Equipment & Services, Penny Stocks

Code: 0256

Website: https://www.umedichealthcare.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

UMC Top Shareholdings

Updated on 29-Sep-2023

Shareholder % Value (M)
Umedic Capital Sdn Bhd 51.44% 66.36
Dato' Ng Chai Eng 24.32% 31.38
Lim Taw Seong 16.7% 21.54
Lau Chee Kheong 4.75% 6.13
Kong Yoen Hoo 2.39% 3.08
Lim Wei Yuen 1.87% 2.41
Lim Suat Gim 1.63% 2.1
Tay Moy Koh 0.72% 0.93
PB Islamic SmallCap Fund 0.59% 0.76
CIMB Bank Berhad 0.58% 0.75
Pmb Shariah Equity Fund 0.54% 0.7
Maybank Malaysia Smallcap Fund 0.48% 0.62
Ng Sze Ling 0.44% 0.57
Fortress Global Growth Fund 0.41% 0.53
United Malaysia Fund 0.4% 0.52
J.P. Morgan Securities plc 0.37% 0.48
Pb Growth Sequel Fund 0.35% 0.45
Tan Ah Nyah 0.3% 0.39
Phillip Master Equity Growth Fund 0.27% 0.35
Tokio Marine Life Insurance Malaysia Berhad 0.27% 0.35
Phillip Pearl Fund 0.26% 0.34
Lim Chin Hon 0.23% 0.3
Quah Zheng Wei 0.23% 0.3
Tan Tio Cheng @ Tan Chow Cheng 0.21% 0.27
Lim Sin Ching 0.21% 0.27
Public E-Islamic Flexi Allocation Fund 0.21% 0.27
Pan Kuan Yen 0.2% 0.26
Ling Siew Luan 0.18% 0.23
Phillip Capital Management Sdn Bhd 0.17% 0.22
Frequently Asked Questions
UMediC Group Berhad is an investment holding company. Through its subsidiaries, the Group is principally involved in the marketing and distribution of various branded medical devices and consumables. It is also engaged in developing, manufacturing, and marketing its medical consumables. The Group is an authorised distributor of multiple established international medical device companies including Philips, Mindray, GE, and Merit. The Group distributes its products to its customers comprising public and private hospitals, other healthcare service providers as well as non-medical business entities. The company was incorporated in 2002 and is headquartered in Pulau Pinang, Malaysia. The company is listed on Bursa Malaysia and operates in the Healthcare, Health Care Equipment & Services and Penny Stocks sectors.
Yes, UMEDIC GROUP BERHAD is listed as Shariah-compliant.
The latest share price of UMEDIC GROUP BERHAD is RM 0.345 updated on 05 December 2025 16:34.
As of now, UMEDIC GROUP BERHAD has a market capitalization of 128M based on the latest financial data.
iSaham's technical analysis indicates that UMEDIC GROUP BERHAD's support level is at RM 0.34 and its resistance level is at RM 0.38, based on moving averages and price patterns.
The 52-week high for UMEDIC GROUP BERHAD is RM 0.435
UMEDIC GROUP BERHAD's share price has decreased by -42.98% year-to-date, influenced by market trends and company performance.
Dividend information for UMEDIC GROUP BERHAD has not been reported yet. Track UMEDIC GROUP BERHAD's upcoming dividend announcements, yield changes, and payout history easily with the iSaham Stock Screener.
The main shareholders of UMEDIC GROUP BERHAD include Umedic Capital Sdn Bhd, Dato' Ng Chai Eng and Lim Taw Seong. View more on UMEDIC GROUP BERHAD Top Shareholders page.
You can buy UMEDIC GROUP BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
UMEDIC GROUP BERHAD Latest News

UMC Insights+


Some features of iSaham Insights are exclusively available to iSaham Pro clients.

Learn More about iSaham Pro

Research House Target Price


Average Target Price: N/A

Entitlements

(Bonus Issue, Share Split or Share consolidation for the past 3 years)

Ex-Date Category Entitlements
No entitlements detected

Private Placements

(Fund raising via private placement shares for the past 3 years)

Date Stage Purpose Issue Price
No Private Placements detected
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.